glp-1 agonists pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? This gentle New GLP-1 Pill Foundayo (Orforglipron)

Participants are included if they reported an adverse effect of GLP-1 agonist and reported the cumulative dose of drug administered

(2021) Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial

Published October 6, 2022.Accessed August 24,2023

The question many researchers are asking is whether a similar jump in results will occur when transitioning from tirzepatide to retatrutide, thanks to that glucagon component

However, it remains unknown whether hepatic GLP-1 resistance contributes to the poor treatment efficiency of GLP-1 in these patients

Were a passionate team obsessed with quality, not margins